NAMD

Clinical trials for NAMD explained in plain language.

Never miss a new study

Get alerted when new NAMD trials appear

Sign up with your email to follow new studies for NAMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1

One-Time gene therapy could free wet AMD patients from lifelong eye injections

Disease control Ongoing

This study tests a one-time gene therapy called RGX-314 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if a single treatment can control the disease and reduce the need for repeated eye injections. About 671 adults a…

Matched conditions: NAMD

Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control

Last updated May 12, 2026 13:41 UTC

NAMD

Get alerted when new NAMD trials appear

One-Time gene therapy could free wet AMD patients from lifelong eye injections